102 related articles for article (PubMed ID: 28684164)
21. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma.
Baral R; Chattopadhyay U
Int Immunopharmacol; 2004 Mar; 4(3):355-66. PubMed ID: 15037213
[TBL] [Abstract][Full Text] [Related]
22. Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NFκB.
Ganguly N; Das T; Bhuniya A; Guha I; Chakravarti M; Dhar S; Sarkar A; Bera S; Dhar J; Dasgupta S; Saha A; Ghosh T; Das J; Sk UH; Banerjee S; Laskar S; Bose A; Baral R
Cell Commun Signal; 2024 Apr; 22(1):237. PubMed ID: 38649988
[TBL] [Abstract][Full Text] [Related]
23. Targeting STAT3 phosphorylation by neem leaf glycoprotein prevents immune evasion exerted by supraglottic laryngeal tumor induced M2 macrophages.
Goswami KK; Barik S; Sarkar M; Bhowmick A; Biswas J; Bose A; Baral R
Mol Immunol; 2014 Jun; 59(2):119-27. PubMed ID: 24607970
[TBL] [Abstract][Full Text] [Related]
24. Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: histological, biochemical and immunological perspectives.
Mallick A; Ghosh S; Banerjee S; Majumder S; Das A; Mondal B; Barik S; Goswami KK; Pal S; Laskar S; Sarkar K; Bose A; Baral R
Int Immunopharmacol; 2013 Jan; 15(1):73-83. PubMed ID: 23178577
[TBL] [Abstract][Full Text] [Related]
25. A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth.
Das A; Barik S; Banerjee S; Bose A; Sarkar K; Biswas J; Baral R; Pal S
J Immunother; 2014 Oct; 37(8):394-406. PubMed ID: 25198527
[TBL] [Abstract][Full Text] [Related]
26. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
[TBL] [Abstract][Full Text] [Related]
27. Restoration of dysregulated CC chemokine signaling for monocyte/macrophage chemotaxis in head and neck squamous cell carcinoma patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity.
Chakraborty K; Bose A; Chakraborty T; Sarkar K; Goswami S; Pal S; Baral R
Cell Mol Immunol; 2010 Sep; 7(5):396-408. PubMed ID: 20622890
[TBL] [Abstract][Full Text] [Related]
28. Neem leaf glycoprotein partially rectifies suppressed dendritic cell functions and associated T cell efficacy in patients with stage IIIB cervical cancer.
Roy S; Goswami S; Bose A; Chakraborty K; Pal S; Haldar A; Basu P; Biswas J; Baral R
Clin Vaccine Immunol; 2011 Apr; 18(4):571-9. PubMed ID: 21307275
[TBL] [Abstract][Full Text] [Related]
29. The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.
Das J; Bera S; Ganguly N; Guha I; Ghosh Halder T; Bhuniya A; Nandi P; Chakravarti M; Dhar S; Sarkar A; Das T; Banerjee S; Ghose S; Bose A; Baral R
Front Immunol; 2024; 15():1325161. PubMed ID: 38585261
[TBL] [Abstract][Full Text] [Related]
30. NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8
Bhuniya A; Guha I; Ganguly N; Saha A; Dasgupta S; Nandi P; Das A; Ghosh S; Ghosh T; Haque E; Banerjee S; Bose A; Baral R
Front Oncol; 2020; 10():201. PubMed ID: 32211313
[TBL] [Abstract][Full Text] [Related]
31. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance.
Chakraborty K; Bose A; Pal S; Sarkar K; Goswami S; Ghosh D; Laskar S; Chattopadhyay U; Baral R
Int Immunopharmacol; 2008 Feb; 8(2):330-40. PubMed ID: 18182249
[TBL] [Abstract][Full Text] [Related]
32. Neem leaf glycoprotein prophylaxis transduces immune dependent stop signal for tumor angiogenic switch within tumor microenvironment.
Banerjee S; Ghosh T; Barik S; Das A; Ghosh S; Bhuniya A; Bose A; Baral R
PLoS One; 2014; 9(11):e110040. PubMed ID: 25391149
[TBL] [Abstract][Full Text] [Related]
33. Neem leaf glycoprotein regulates function of tumor associated M2 macrophages in hypoxic tumor core: Critical role of IL-10/STAT3 signaling.
Goswami KK; Sarkar M; Ghosh S; Saha A; Ghosh T; Guha I; Barik S; Banerjee S; Roy S; Bose A; Dasgupta P; Baral R
Mol Immunol; 2016 Dec; 80():1-10. PubMed ID: 27776244
[TBL] [Abstract][Full Text] [Related]
34. CD40 ligand-expressing recombinant vaccinia virus promotes the generation of CD8(+) central memory T cells.
Trella E; Raafat N; Mengus C; Traunecker E; Governa V; Heidtmann S; Heberer M; Oertli D; Spagnoli GC; Zajac P
Eur J Immunol; 2016 Feb; 46(2):420-31. PubMed ID: 26561341
[TBL] [Abstract][Full Text] [Related]
35. Induction of type 1 cytokines during neem leaf glycoprotein assisted carcinoembryonic antigen vaccination is associated with nitric oxide production.
Sarkar K; Bose A; Haque E; Chakraborty K; Chakraborty T; Goswami S; Ghosh D; Baral R
Int Immunopharmacol; 2009 Jun; 9(6):753-60. PubMed ID: 19285575
[TBL] [Abstract][Full Text] [Related]
36. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes.
Khan AA; Srivastava R; Spencer D; Garg S; Fremgen D; Vahed H; Lopes PP; Pham TT; Hewett C; Kuang J; Ong N; Huang L; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Apr; 89(7):3776-92. PubMed ID: 25609800
[TBL] [Abstract][Full Text] [Related]
38. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.
Kosaka A; Wakita D; Matsubara N; Togashi Y; Nishimura S; Kitamura H; Nishimura T
Int Immunol; 2007 Mar; 19(3):249-56. PubMed ID: 17229818
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice.
Gough MJ; Crittenden MR; Sarff M; Pang P; Seung SK; Vetto JT; Hu HM; Redmond WL; Holland J; Weinberg AD
J Immunother; 2010 Oct; 33(8):798-809. PubMed ID: 20842057
[TBL] [Abstract][Full Text] [Related]
40. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
